Oligoastrocytoma classification: Difference between revisions
(Mahshid) |
No edit summary |
||
Line 17: | Line 17: | ||
{{Family tree |boxstyle=background: #F5F5F5;| C01 | | | | C02 |C01=<div style="width: 15em; padding:1em;"> '''Oligoastrocytoma (OAII)'''</div>| C02=<div style="width: 15em; padding:1em;"> '''Anaplastic oligoastrocytoma (OAIII)'''</div>}} | {{Family tree |boxstyle=background: #F5F5F5;| C01 | | | | C02 |C01=<div style="width: 15em; padding:1em;"> '''Oligoastrocytoma (OAII)'''</div>| C02=<div style="width: 15em; padding:1em;"> '''Anaplastic oligoastrocytoma (OAIII)'''</div>}} | ||
{{Family tree/end}} | {{Family tree/end}} | ||
There is no established system for the classification of [disease name]. | |||
OR | |||
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: | |||
[Group1] | |||
[Group2] | |||
[Group3] | |||
[Group4] | |||
OR | |||
[Disease name] may be classified into [large number > 6] subtypes based on: | |||
[Classification method 1] | |||
[Classification method 2] | |||
[Classification method 3] | |||
[Disease name] may be classified into several subtypes based on: | |||
[Classification method 1] | |||
[Classification method 2] | |||
[Classification method 3] | |||
OR | |||
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | |||
OR | |||
If the staging system involves specific and characteristic findings and features: | |||
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | |||
OR | |||
The staging of [malignancy name] is based on the [staging system]. | |||
OR | |||
There is no established system for the staging of [malignancy name]. | |||
==Reference== | ==Reference== |
Revision as of 12:18, 18 July 2019
Oligoastrocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oligoastrocytoma classification On the Web |
American Roentgen Ray Society Images of Oligoastrocytoma classification |
Risk calculators and risk factors for Oligoastrocytoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Oligoastrocytoma may be classified according to the WHO classification of the central nervous system tumors into two subtypes: oligoastrocytoma (OAII) and anaplastic oligoastrocytoma (OAIII).[1]
Classification
Oligoastrocytoma may be classified according to the WHO classification of the central nervous system tumors into two subtypes:[1]
WHO classification of tumors of CNS | |||||||||||||||||||||
WHO grade II | WHO grade III | ||||||||||||||||||||
Oligoastrocytoma (OAII) | Anaplastic oligoastrocytoma (OAIII) | ||||||||||||||||||||
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
[Group1]
[Group2]
[Group3]
[Group4]
OR
[Disease name] may be classified into [large number > 6] subtypes based on:
[Classification method 1]
[Classification method 2]
[Classification method 3]
[Disease name] may be classified into several subtypes based on:
[Classification method 1]
[Classification method 2]
[Classification method 3]
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Reference
- ↑ 1.0 1.1 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A; et al. (2007). "The 2007 WHO classification of tumours of the central nervous system". Acta Neuropathol. 114 (2): 97–109. doi:10.1007/s00401-007-0243-4. PMC 1929165. PMID 17618441.